首页 | 本学科首页   官方微博 | 高级检索  
     

细胞角蛋白18联合受控衰减参数对慢性乙肝合并代谢相关脂肪性肝病的诊断价值
引用本文:赵黎莉,李嘉,王春妍. 细胞角蛋白18联合受控衰减参数对慢性乙肝合并代谢相关脂肪性肝病的诊断价值[J]. 实用器官移植电子杂志, 2021, 0(1): 37-41
作者姓名:赵黎莉  李嘉  王春妍
作者单位:天津市第二人民医院肝病科
基金项目:天津市第二人民医院院所级项目(YS-0014)。
摘    要:目的 探讨血清细胞角蛋白18片段M 30(CK18M30)及片段M65(CK18M65)、血脂、受控衰减参数(controlled attenuation parameter,CAP)在慢性乙肝(chronic hepatitis B,CHB)合并代谢相关脂肪性肝病(metabolic-dysfunction-asso...

关 键 词:慢性乙肝  代谢相关性脂肪性肝病  细胞角蛋白18  受控衰减参数  血脂  诊断

Diagnostic value of CAP,cytokeratin 18 and low-density lipoprotein cholesterolfor chronic hepatitis B with metabolic-dysfunction-associated fatty liver disease
Zhao Lili,Li Jia,Wang Chunyan. Diagnostic value of CAP,cytokeratin 18 and low-density lipoprotein cholesterolfor chronic hepatitis B with metabolic-dysfunction-associated fatty liver disease[J]. Practical Journal of Organ Transplantation(Electronic Version), 2021, 0(1): 37-41
Authors:Zhao Lili  Li Jia  Wang Chunyan
Affiliation:(Department of Gastroenterology and Hepatology,Tianjin Second People’s Hospital,Tianjin 300192,China)
Abstract:Objective To investigate the diagnostic value of cytokeratin 18 M30(CK18M30)and M65(CK18M65),blood lipids and controlled attenuation parameter(CAP)in chronic hepatitis B(CHB)with metabolicdysfunction-associated fatty liver disease(MAFLD).Methods A total of 105 CHB patients concomitant with MAFLD patients were included from April 2019 to April 2020 were.Serum CK18M30,CK18M65 levels were measured by enzyme linked immunosorbent assay(ELISA);CAP was measured by Fibroscan;and ultrasonography was used to assessed the extent of hepatic steatosis.The index of serum CK18,blood lipids and CAP was analyzed by binary logistic regression,and the diagnostic value of the above indexes for CHB with MAFLD was evaluated by the areas under the receiver operating characteristic curve(AUC).Results ALT,AST,ALP,GGT,FBG,HDL,CK18M30 levels between MAFLD,CHB and CHB with MAFLD groups showed no significant statistical difference (P > 0.05). Compared to CHB group, the levels of CAP, TC, LDL and BMI were significantly higher in MAFLDand CHB with MAFLD groups(P < 0.05). CK18M65 level in CHB with MAFLD group was significantly higherthan in MAFLD and CHB groups(P < 0.05). The AUC of CK18M30, CK18M65, CAP, CAP-CK18M65, CAPCK18M65-TC and CAP-CK18M65-LDL for the diagnosis of CHB with MAFLD were 0.572(0.455 ~ 0.683),0.651(0.535 ~ 0.755), 0.737(0.626 ~ 0.830), 0.774(0.666 ~ 0.860), 0.797(0.691 ~ 0.879) and 0.837(0.728 ~0.915), respectively. Among the parameters, the combination of CAP, CK18M65 and LDL had the largest AUC andthe corresponding sensitivity and specificity were 0.811 and 0.719, respectively. Conclusion The combination ofCAP, CK18M65 and LDL has a superior diagnostic diagnastic value for CHB with MAFLD.
Keywords:Chronic hepatitis B  Metabolic-dysfunction-associated fatty liver disease  Cytokeratin 18  Controlled attenuation parameter  Blood lipids  Diagnosis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号